Investigational Site Number :1240006

Sherbrooke, Quebec J1L 0H8

0 studies enrolling now · 2 studies all time

What they study most

Cold Urticaria, Multiple Sclerosis

Studies at this site

• Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis — Running, not enrolling
• Dupilumab for the Treatment of Chronic Inducible Cold Urticaria in Patients Who Remain Symptomatic Despite the Use of H1-antihistamine (LIBERTY-CINDU CUrIADS) — Completed